Purchase Order 75N91020K20034
- Not listed
- This firm-fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. government, to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The $20,000.00 contract is for the procurement of a multi-mode microplate detection platform and does not have a set-aside designation. As a leading provider of advanced bioanalytical measurement solutions to federal...
- This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a service agreement with a potential value of $10,217.00. The contract does not have a set-aside designation and is scheduled for completion on June 8, 2025. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, such as...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $4,216 contract is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $9,676.00 contract is for depot service and repair of M2-M5 serial number MV02471 equipment. This award does not have a set-aside designation. Molecular Devices LLC is a leading provider of specialized bioanalytical measurement solutions, including...
- This is a $10,217 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a service agreement with an ultimate completion date of August 8, 2025. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company often receives sole-source awards as the original...
- This is a $24,540.00 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading manufacturer of high-performance bioanalytical measurement solutions for pharmaceutical and...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The $3,777 contract is for "OTHER FUNCTIONS" and does not have a set-aside designation. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions, including microplate readers, high-content imaging systems, and...
- The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $23,525.00 on August 20, 2019, for scientific equipment, with performance scheduled through September 30, 2019. Work is performed in San Jose, California. Molecular Devices, a subsidiary of Danaher Corporation, manufactures bioanalytical laboratory instruments including microplate readers, high-content imaging systems, and electrophysiology equipment sold to federal research agencies on a full-and-open,...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services. The $57,545.00 contract is for a service agreement to provide laboratory equipment from Molecular Devices LLC, a division of Danaher Corporation. The contract does not have a set-aside designation and has an ultimate completion date of October 31, 2023. Molecular Devices LLC, as the...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for onsite performance assurance and one-time preventative maintenance service for the agency's Molecular Devices instruments. The contract has a ceiling value of $14,555.00 and an ultimate completion date of October 17, 2025. Molecular Devices LLC is a leading provider of bioanalytical...
This firm-fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The $5,402.27 contract does not have a set-aside designation and is for the procurement of specialized scientific equipment and services, including microplate readers, high-content imaging systems, electrophysiology equipment, and cellular screening platforms, along with associated software and maintenance. Molecular Devices LLC is a manufacturer of high-performance bioanalytical measurement solutions that supports medical research, drug discovery, and scientific exploration across various federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($6k) | 9/29/25 | |
| Not listed | Not listed | $11.0k | 8/20/20 |